CLINICAL TRIALS PROFILE FOR CAMBIA
✉ Email this page to a colleague
All Clinical Trials for CAMBIA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00276419 ↗ | Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin | Terminated | Mayo Clinic | Phase 2/Phase 3 | 2005-06-01 | The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain. |
| NCT02287376 ↗ | Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds | Completed | Depomed | Phase 4 | 2015-01-01 | Study Objectives: 1. The primary objective is to characterize the pharmacokinetics of a single oral administration of 50 mg Cambia in pediatric subjects, ages 12-17 years with a diagnosis of episodic migraine with or without aura. 2. The secondary objectives are to determine: 1. The safety and tolerability of Cambia from a single dose 2. Three-month safety evaluation of Cambia in outpatient usage in this population |
| NCT02664116 ↗ | IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine | Unknown status | Depomed | Phase 4 | 2016-01-01 | This research will be conducted to see if the oral drug Cambia is as effective in relieving severe migraine headaches as the injectable drug ketorolac. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CAMBIA
Condition Name
Clinical Trial Locations for CAMBIA
Trials by Country
Clinical Trial Progress for CAMBIA
Clinical Trial Phase
Clinical Trial Sponsors for CAMBIA
Sponsor Name
